Protein Phosphatase 5 (PP5) activators encompass a range of chemicals that either directly or indirectly enhance the activity of PP5. The direct activators of PP5 are not well-characterized, making the focus shift towards indirect activators. These indirect activators primarily work by modulating the cellular environment or influencing other proteins that, in turn, affect PP5 activity. For instance, agents that elevate cAMP levels, like Forskolin and Dibutyryl-cAMP, can lead to PP5 activation through a cascade involving protein kinase A (PKA). This indirect activation is crucial in understanding PP5's role in various cellular processes.
Another significant aspect of PP5 regulation involves the use of inhibitors for other protein phosphatases such as PP1 and PP2A. Chemicals like Okadaic Acid, Calyculin A, Cantharidin, Tautomycin, and Endothall are known to inhibit PP1 and PP2A. This inhibition can result in a compensatory increase in PP5 activity, highlighting an indirect route of activation. These chemicals often serve as tools to dissect the complex regulatory networks involving PP5. For example, Microcystin-LR and OA-NO2, potent PP1 and PP2A inhibitors, can indirectly augment PP5 activity. Additionally, Nitric Oxide (NO) donors like Spermine NONOate, which modulate protein function through nitrosylation, can indirectly influence PP5. NO's role in signaling pathways adds another layer to the regulation of PP5.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin indirectly activates PP5 by elevating cAMP levels, which can lead to the activation of PP5 through PKA-dependent mechanisms. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid, a potent inhibitor of other protein phosphatases like PP1 and PP2A, can indirectly upregulate PP5 activity by reducing competitive inhibition. | ||||||
Cantharidin | 56-25-7 | sc-201321 sc-201321A | 25 mg 100 mg | $89.00 $279.00 | 6 | |
Cantharidin inhibits PP2A and PP1, which may indirectly enhance PP5 activity due to reduced competition. | ||||||
Endothall | 145-73-3 | sc-201325 sc-201325A | 20 mg 100 mg | $49.00 $203.00 | 1 | |
Endothall, an inhibitor of PP2A and PP1, may indirectly increase PP5 activity. | ||||||
9-Nitrooleate | 875685-44-2 | sc-204632 sc-204632A sc-204632B sc-204632C | 50 µg 100 µg 1 mg 10 mg | $58.00 $90.00 $622.00 $6144.00 | ||
9-Nitrooleate, an Okadaic Acid derivative, inhibits PP2A and PP1, potentially allowing for increased PP5 activity. | ||||||
Spermine NONOate | 136587-13-8 | sc-202816 sc-202816A | 5 mg 25 mg | $53.00 $196.00 | 5 | |
Spermine NONOate releases NO, which can modulate PP5 activity indirectly through nitrosylation. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP elevates cAMP levels, potentially leading to indirect PP5 activation through PKA-dependent pathways. | ||||||